ARGNF:OTCMKTS
argenx SE
$936.00
0.00%
(0.00) 1D
Oct 1, 2:37:17 PM GMT-4 · USD
search
All symbols
| Symbol | Price | Change | % Change |
|---|
insights_autoGenerating top insights for ARGNF...
Mkt. cap
58.78B
Avg. vol.
14.00
Volume
0.00
52-wk high
$1,020.00
52-wk low
$708.72
Beta
0.46
Shares outstanding
62.56M
No. of employees
2K
Mkt. cap
58.78B
Avg. vol.
14.00
Volume
0.00
52-wk high
$1,020.00
52-wk low
$708.72
Beta
0.46
Shares outstanding
62.56M
No. of employees
2K
News stories
From web sources and news partners
AD HOC NEWS
·
5 hours ago
Argenx stock after-hours: EUR 839.00, prior close EUR 828.90
Yahoo! Finance Canada
·
7 hours ago
HALO Expands ENHANZE Collaboration & Licensing Deal With ARGX
AD HOC NEWS
·
9 hours ago
Argenx stock gained 1.93 percent as pipeline access expands
AD HOC NEWS
·
14 hours ago
Goldman Sachs raises target for Argenx stock to EUR 982.00
Profile
Argenx SE is a Belgian-Dutch pharmaceutical company specializing in immunology. Argenx specializes in the development of antibody therapies for the treatment of autoimmune diseases and cancer. Its work primarily focuses on the development of orphan drugs. Wikipedia
About argenx SE